RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eli Lilly and Co Stock

Eli Lilly and Co Market capitalization 2024

Eli Lilly and Co Market capitalization

749.58 B USD

Ticker

LLY

ISIN

US5324571083

WKN

858560

In 2024, Eli Lilly and Co's market cap stood at 749.58 B USD, a 44.46% increase from the 518.88 B USD market cap in the previous year.

The Eli Lilly and Co Market capitalization history

YEARMarket Capitalization (undefined USD)
2023420
2022278.31
2021196.98
2020135.84
2019109.13
201896.82
201786.48
201681.12
201584
201466.21
201357.16
201248.66
201141.04
201038.88
200937.7
200849.85
200760.54
200659.88
200560.08
200471.74

Eli Lilly and Co Aktienanalyse

What does Eli Lilly and Co do?

Eli Lilly and Co. is a global biopharmaceutical company headquartered in Indianapolis, Indiana, USA. The company was founded in 1876 by Colonel Eli Lilly with the aim of manufacturing pharmaceutical products of the highest quality. Eli Lilly began his career in the pharmacy industry and opened his own pharmacy in Indianapolis in 1876. He quickly developed his own medications and eventually established Eli Lilly and Company in 1901. Over the years, the company has continued to evolve and expand its business into numerous areas. Eli Lilly is focused on biopharmaceutical research and development and operates in areas such as oncology, diabetes, neurology, and others. The company's main goal is to develop drugs that can change and improve lives. Eli Lilly invests a high percentage of its revenue into research and development every year. The company has several strategic business units, including human pharmaceuticals, animal pharmaceuticals, and oncology research. Eli Lilly is divided into five main divisions: diabetes, oncology, immunology, neurology, and animal health. The diabetes division focuses on manufacturing insulin products and glucose sensors for the treatment of type 1 and type 2 diabetes, as well as blood glucose meters and other diabetes products. The oncology division focuses on researching and developing drugs to treat cancer. The company currently has several compounds in clinical trials, including a new preparation for the treatment of breast cancer. The immunology division focuses on products for the treatment of autoimmune and inflammatory diseases, such as psoriasis. The neurology division focuses on researching and developing drugs to treat diseases of the nervous system, such as Alzheimer's. The animal health division focuses on animal health products, such as drugs for the treatment of infections in livestock and pets. Eli Lilly is primarily known for its insulin products and treatments in the field of oncology. Some of the company's most well-known products include Humalog, Forteo, Alimta, and Cymbalta. The effectiveness and compliance of the products are monitored by a quality and safety system to ensure that patients receive the highest quality medications. In conclusion, Eli Lilly and Co. is a company with a long history and a unique business model. The company specializes in developing high-quality pharmaceutical products and has continued to evolve since its founding. Eli Lilly has become a leader in various areas such as diabetes, oncology, immunology, neurology, and animal health. They are known for their insulin products and treatments in the field of oncology. The company remains committed to expanding its reach and presence globally and continues to develop innovative products that can improve and change people's lives. Eli Lilly and Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Eli Lilly and Co's Market Capitalization

Eli Lilly and Co's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Eli Lilly and Co's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Eli Lilly and Co's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Eli Lilly and Co’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Eli Lilly and Co stock

What is the current Eli Lilly and Co market capitalization?

The current market capitalization of Eli Lilly and Co is 749.58 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Eli Lilly and Co.

How has the market capitalization of Eli Lilly and Co developed in recent years?

The market capitalization of Eli Lilly and Co has increased/decreased by 44.46% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Eli Lilly and Co?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Eli Lilly and Co?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Eli Lilly and Co have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Eli Lilly and Co pay?

Over the past 12 months, Eli Lilly and Co paid a dividend of 4.52 USD . This corresponds to a dividend yield of about 0.54 %. For the coming 12 months, Eli Lilly and Co is expected to pay a dividend of 5.73 USD.

What is the dividend yield of Eli Lilly and Co?

The current dividend yield of Eli Lilly and Co is 0.54 %.

When does Eli Lilly and Co pay dividends?

Eli Lilly and Co pays a quarterly dividend. This is distributed in the months of March, June, September, December.

How secure is the dividend of Eli Lilly and Co?

Eli Lilly and Co paid dividends every year for the past 26 years.

What is the dividend of Eli Lilly and Co?

For the upcoming 12 months, dividends amounting to 5.73 USD are expected. This corresponds to a dividend yield of 0.69 %.

In which sector is Eli Lilly and Co located?

Eli Lilly and Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eli Lilly and Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eli Lilly and Co from 12/10/2024 amounting to 1.3 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Eli Lilly and Co pay the last dividend?

The last dividend was paid out on 12/10/2024.

What was the dividend of Eli Lilly and Co in the year 2023?

In the year 2023, Eli Lilly and Co distributed 3.92 USD as dividends.

In which currency does Eli Lilly and Co pay out the dividend?

The dividends of Eli Lilly and Co are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Eli Lilly and Co stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Eli Lilly and Co

Our stock analysis for Eli Lilly and Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eli Lilly and Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.